News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Capital VIII, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/23/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 758,620 shares
@ $7.25, valued at
$5.5M
|
|
| 09/08/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $3.6, valued at
$2.2M
|
|
| 08/16/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 1,123,021 shares
@ $2.98, valued at
$3.3M
Bought 1,218 shares
@ $2.99, valued at
$3.6k
Bought 1,500,000 shares
@ $2.42, valued at
$3.6M
Bought 1,500,000 options to buy
@ $0.0001, valued at
$150 |
|
| 02/11/2022 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 7.4% stake in Harmony Biosciences Holdings, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 0% stake in Crinetics Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/06/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/18/2021 |
SC 13G
| Vivo Capital VIII, LLC reports a 6.6% stake in Bolt Biotherapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 5.5% stake in Crinetics Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 2.8% stake in Passage Bio, Inc. |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Converted 1,933,185 shares
@ $0
Converted 266,948 shares
@ $0
Bought 103,372 shares
@ $17, valued at
$1.8M
Bought 14,275 shares
@ $17, valued at
$242.7k
Bought 357,353 shares
@ $17, valued at
$6.1M
Converted 713,203 preferred shares
@ $0
Converted 98,484 preferred shares
@ $0
Converted 364,138 preferred shares
@ $0
Converted 50,282 preferred shares
@ $0 |
|
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/04/2021 |
3
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 3 on Terns Pharmaceuticals, Inc. |
| 10/28/2020 |
SC 13G
| Vivo Capital VIII, LLC reports a 10.5% stake in Aligos Therapeutics, Inc. |
| 10/20/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 1,885,611 shares
@ $0
Converted 523,726 shares
@ $0
Converted 224,054 shares
@ $0
Converted 260,380 shares
@ $0
Converted 72,320 shares
@ $0
Converted 30,939 shares
@ $0
Bought 483,267 shares
@ $15, valued at
$7.2M
Bought 66,733 shares
@ $15, valued at
$1M
Converted 1,885,611 preferred shares
@ $0
Converted 260,380 preferred shares
@ $0
Converted 523,726 preferred shares
@ $0 |
|
| 10/15/2020 |
3
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 3 on Aligos Therapeutics, Inc. |
| 06/11/2020 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 2.2% stake in Menlo Therapeutics Inc. |
| 06/11/2020 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 6.8% stake in Crinetics Pharmaceuticals, Inc. |
| 04/17/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 189,625 shares
@ $15.5, valued at
$2.9M
Sold 26,185 shares
@ $15.5, valued at
$405.9k
Sold 26,527 shares
@ $15.2, valued at
$403.2k
Sold 3,663 shares
@ $15.2, valued at
$55.7k
Sold 74,333 shares
@ $15.4, valued at
$1.1M
Sold 10,265 shares
@ $15.4, valued at
$158.1k
|
|
| 04/07/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 263,600 shares
@ $13.8, valued at
$3.6M
Sold 36,400 shares
@ $13.8, valued at
$502.3k
Sold 5,373 shares
@ $14.2, valued at
$76.3k
Sold 742 shares
@ $14.2, valued at
$10.5k
|
|
| 03/11/2020 |
4
| Vivo Capital VIII, LLC (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 347 shares
@ $19.5, valued at
$6.8k
Sold 48 shares
@ $19.5, valued at
$936
Sold 133 shares
@ $19.5, valued at
$2.6k
|
|
| 03/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 12.8% stake in Crinetics Pharmaceuticals, Inc. |
|
|
|